Fennec Pharmaceuticals (FENC) Reveals Stunning Japan Trial Data—Hearing Loss Drops from 63% to Just 24%
Fennec Pharmaceuticals (NASDAQ:FENC) is a specialty pharmaceutical company built on the mission of addressing one of the most…
Browsing Tag